- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Vaccine Development for Zika Virus—Timelines and Strategies ; volume:34 ; number:05 ; year:2016 ; pages:299-304
Seminars in reproductive medicine ; 34, Heft 05 (2016), 299-304
- Beteiligte Personen und Organisationen
-
Durbin, Anna P.
- DOI
-
10.1055/s-0036-1592070
- URN
-
urn:nbn:de:101:1-2018090607061279234541
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Durbin, Anna P.
Ähnliche Objekte (12)
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
E90 subunit vaccine protects mice from Zika virus infection and microcephaly
A VSV-based Zika virus vaccine protects mice from lethal challenge
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice
Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
E90 subunit vaccine protects mice from Zika virus infection and microcephaly
A VSV-based Zika virus vaccine protects mice from lethal challenge
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice
Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
E90 subunit vaccine protects mice from Zika virus infection and microcephaly
A VSV-based Zika virus vaccine protects mice from lethal challenge
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice
Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine